Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension

NCT07142356 is registered in ClinicalTrials.gov with Retension Pharmaceuticals. Inc. as lead sponsor.

NCT NCT07142356
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07142356 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension
Lead sponsor
Retension Pharmaceuticals. Inc.
Phase
Phase 2
Overall status
Recruiting
Start date
October 31, 2025
Completion date
June 30, 2027
Enrollment
280 (estimated)
Sites
34

Conditions

As the registry lists them; a condition with its own page is linked.

uncontrolled hypertension